NEUROPATHIC PAIN MARKET ANALYSIS

Neuropathic Pain Market, by Drug Class (Tricyclic Anti-Depressant, Anticonvulsant, Local Anaesthesia, Opioids, Steroids, Others), By Indication (Diabetic neuropathy, Chemotherapy-induced Peripheral neuropathy and Others), By Distribution Channel (Retail Pharmacies, Drug Store and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jul 2023
Code : CMI3656
Pages :168
Formats :
Excel and PDF
Industry : Pharmaceutical

Neuropathic Pain MarketSize and Trends

The Global Neuropathic Pain Market is estimated to be valued at US$ 7.56 Billion in 2023 and is expected to exhibit a CAGR of 6.2% during the forecast period (2023-2030).

Figure 1. Global Neuropathic Pain Market Share (%), by Drug class, 2023

Figure 2. Global Neuropathic Pain Market Value (US$ Billion), by Region, 2023

Global Neuropathic Pain Market – Market Trends

Several studies have demonstrated that electroacupuncture can be effective in decreasing neuropathic pain. For instance, in January 2020, researchers from Huazhong Agricultural University, China, demonstrated that Synaptotagmin 1 (Syt-1), a synaptic vesicle protein for regulating exocytosis of neurotransmitters, impairs neuropathic pain and that electroacupuncture relieves neuropathic pain through down-regulating spinal Syt-1.